A previous report of triple-negative breast cancer demonstrated that a marked reduction in the percentage of CD8+ T lymphocytes and a significant increase in the frequencies of CD4+ T lymphocytes and CD4+ and CD8+ T lymphocytes expressing PD1 and CD39 were evident in tumor tissue in comparison with the normal breast tissue [26]. The gene discussed is ENTPD1; the disease is triple-negative breast carcinoma.